ReviewWorld journal of cardiology2020
Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy.
Review in World journal of cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Safety and evidence of COEuropean radiology · 2025Pooled it
- Carbon dioxide as a promising alternative to iodinated contrast media for lower extremity endovascular procedures (Review).Biomedical reports · 2026Review
- Article
- Management of Acute Infrainguinal Graft Occlusion: Surgical and Endovascular Approaches in Contemporary Practice.Journal of personalized medicine · 2025Review
- Carbon Dioxide Digital Subtraction Angiography for Central Venous Recanalization in a Kidney Transplant Patient: A Case Report.Hemodialysis international. International Symposium on Home Hemodialysis · 2025Article
- Acute Kidney Injury After Peripheral Interventions Using Carbon Dioxide Angiography-Risk Factors Beyond Iodinated Contrast Media.Life (Basel, Switzerland) · 2025Article
- Clinical management of peripheral arterial disease in chronic kidney disease-a comprehensive review from the European Renal Association CKD-MBD Working Group.Clinical kidney journal · 2025Review
- The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment.Turkish journal of medical sciences · 2025Article
- Atherosclerotic plaque composition and specific endovascular considerations in the end stage renal disease patients: a narrative review.Cardiovascular diagnosis and therapy · 2023Review
- Risk of Contrast-Associated Acute Kidney Injury in Patients Undergoing Peripheral Angiography with Carbon Dioxide Compared to Iodine-Containing Contrast Agents: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2022Review
- Digital Variance Angiography in Selective Lower Limb Interventions.Journal of vascular and interventional radiology : JVIR · 2022Article
- Clinical value and feasibility of CT pulmonary angiography with personalized injection of contrast agent in pulmonary embolism.American journal of translational research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with peripheral arterial disease (PAD) and critical limb ischemia are at risk for limb amputation and require urgent management to restore blood flow. Patients with PAD often have several comorbidities, including chronic kidney disease, diabetes mellitus, and hypertension. Diagnostic and interventional angiography using iodinated contrast agents provides excellent image resolution but can be associated with contrast-induced nephropathy (CIN). The use of carbon dioxide (CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.